Your browser doesn't support javascript.
loading
Carfilzomib for Treatment of Refractory Chronic Graft-versus-Host Disease: A Chronic GVHD Consortium Pilot Phase II Trial.
Pidala, Joseph; Jaglowski, Samantha; Im, Annie; Chen, George; Onstad, Lynn; Storer, Barry; Kurukulasuriya, Chareeni; Lee, Stephanie J.
Afiliação
  • Pidala J; Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida. Electronic address: Joseph.Pidala@moffitt.org.
  • Jaglowski S; Division of Hematology, Department of Internal Medicine, The Ohio State University Medical Center, Columbus, Ohio.
  • Im A; Division of Hematology and Oncology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Chen G; Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York.
  • Onstad L; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.
  • Storer B; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.
  • Kurukulasuriya C; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington.
  • Lee SJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.
Biol Blood Marrow Transplant ; 26(2): 278-284, 2020 02.
Article em En | MEDLINE | ID: mdl-31499215
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Enxerto-Hospedeiro Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Enxerto-Hospedeiro Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article